Pasithea Therapeutics Corp. (KTTA)
NASDAQ: KTTA · Real-Time Price · USD
0.8816
+0.0439 (5.24%)
At close: Feb 27, 2026, 4:00 PM EST
0.8400
-0.0416 (-4.72%)
After-hours: Feb 27, 2026, 7:40 PM EST
Pasithea Therapeutics Market Cap
Pasithea Therapeutics has a market cap or net worth of $20.36 million as of February 27, 2026. Its market cap has increased by 1,024.09% in one year.
Market Cap
20.36M
Enterprise Value
16.23M
1-Year Change
1,024.09%
Ranking
Category
Stock Price
$0.88
Market Cap Chart
Since the IPO on September 15, 2021, Pasithea Therapeutics's market cap has decreased from $65.29M to $20.36M, a decrease of -68.82%. That is a compound annual growth rate of -23.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 20.36M | -31.66% |
| Dec 31, 2025 | 29.79M | 646.69% |
| Dec 31, 2024 | 3.99M | -48.26% |
| Dec 29, 2023 | 7.71M | -58.92% |
| Dec 30, 2022 | 18.77M | -51.55% |
| Dec 31, 2021 | 38.74M | -40.66% |
| Sep 15, 2021 | 65.29M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Polyrizon | 21.82M |
| NanoViricides | 21.60M |
| Intensity Therapeutics | 19.76M |
| VYNE Therapeutics | 19.76M |
| Cadrenal Therapeutics | 19.59M |
| Jupiter Neurosciences | 19.53M |
| Serina Therapeutics | 19.52M |
| FibroBiologics | 18.82M |